{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:38:54Z","timestamp":1792143534020,"version":"4.4.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,7,26]],"date-time":"2014-07-26T00:00:00Z","timestamp":1406332800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s12185-014-1630-y","type":"journal-article","created":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T07:16:56Z","timestamp":1406272616000},"page":"507-510","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation"],"prefix":"10.1007","volume":"100","author":[{"given":"Hideki","family":"Tsujimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiko","family":"Miyaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeaki","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Ise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Yonemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Ikebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Itami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoya","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,26]]},"reference":[{"key":"1630_CR1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/01.pas.0000131541.95394.23","volume":"28","author":"JL Hornick","year":"2004","unstructured":"Hornick JL, Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol. 2004;28:1133\u201344.","journal-title":"Am J Surg Pathol"},{"key":"1630_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.53.1","volume":"53","author":"E Takahashi","year":"2013","unstructured":"Takahashi E, Nakamura S. Histiocytic sarcoma : an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop. 2013;53:1\u20138.","journal-title":"J Clin Exp Hematop"},{"key":"1630_CR3","first-page":"356","volume-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues","author":"TM Grogan","year":"2008","unstructured":"Grogan TM, Pileri S, Chan JKC. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. p. 356\u20137.","edition":"4"},{"key":"1630_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12185-012-1245-0","volume":"97","author":"A Morimoto","year":"2013","unstructured":"Morimoto A, Shimazaki C, Takahashi S, et al. Therapeutic outcome of multifocal Langerhans cell histiocytosis in adults treated with the special C regimen formulated by the Japan LCH study group. Int J Hematol. 2013;97:103\u20138.","journal-title":"Int J Hematol"},{"issue":"Suppl 3","key":"1630_CR5","first-page":"163","volume":"10","author":"K Kumagai","year":"1999","unstructured":"Kumagai K, Tsuimura H, Sakai C, Takagi T. CHOP-ABVP therapy and upfront autologous peripheral blood stem cell transplantation (PBSCT) in the treatment of aggressive non-Hodgkin\u2019s lymphoma (NHL): a pilot study. Ann Oncol. 1999;10(Suppl 3):163.","journal-title":"Ann Oncol"},{"key":"1630_CR6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/modpathol.3800346","volume":"18","author":"JA Vos","year":"2005","unstructured":"Vos JA, Abbondanzo SL, Barekman CL, et al. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol. 2005;18:693\u2013704.","journal-title":"Mod Pathol"},{"key":"1630_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2559.2002.01418.x","volume":"41","author":"SA Pileri","year":"2002","unstructured":"Pileri SA, Grogan TM, Harris NL, et al. Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology. 2002;41:1\u201329.","journal-title":"Histopathology"},{"key":"1630_CR8","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.3747\/co.19.964","volume":"19","author":"A Abu-Sanad","year":"2012","unstructured":"Abu-Sanad A, Warsi A, Michel RP, et al. Long-term remission after autologous stem-cell transplantation for relapsed histiocytic sarcoma. Curr Oncol. 2012;19:e289\u201391.","journal-title":"Curr Oncol"},{"key":"1630_CR9","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1200\/JCO.2010.32.6603","volume":"29","author":"U Gergis","year":"2011","unstructured":"Gergis U, Dax H, Ritchie E, et al. Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature. J Clin Oncol. 2011;29:e251\u20133.","journal-title":"J Clin Oncol"},{"key":"1630_CR10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/10428194.2012.717082","volume":"54","author":"A Zeidan","year":"2013","unstructured":"Zeidan A, Bolanos-Meade J, Kasamon Y, et al. Human leukocyte antigen-haploidentical hematopoietic stem cell transplant for a patient with histiocytic sarcoma. Leuk Lymphoma. 2013;54:655\u20137.","journal-title":"Leuk Lymphoma"},{"key":"1630_CR11","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood.V99.8.2685","volume":"99","author":"WH Wilson","year":"2002","unstructured":"Wilson WH, Grossbard ML, Pittaluga S, et al. Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy. Blood. 2002;99:2685\u201393.","journal-title":"Blood"},{"key":"1630_CR12","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood-2003-06-2094","volume":"104","author":"M Pfreundschuh","year":"2004","unstructured":"Pfreundschuh M, Trumper L, Kloess M, et al. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL. Blood. 2004;104:626\u201333.","journal-title":"Blood"},{"key":"1630_CR13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3109\/10428194.2011.565840","volume":"52","author":"C Mainardi","year":"2011","unstructured":"Mainardi C, D\u2019Amore ES, Pillon M, et al. A case of resistant pediatric histiocytic sarcoma successfully treated with chemo-radiotherapy and autologous peripheral blood stem cell transplant. Leuk Lymphoma. 2011;52:1367\u201371.","journal-title":"Leuk Lymphoma"},{"key":"1630_CR14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2169\/internalmedicine.48.1295","volume":"48","author":"KC Kawabata","year":"2009","unstructured":"Kawabata KC, Hagiwara S, Takenouchi A, et al. Autologous stem cell transplantation using MEAM regimen for relapsed AIDS-related lymphoma patients who received highly active anti-retroviral therapy: a report of three cases. Intern Med. 2009;48:111\u20134.","journal-title":"Intern Med"},{"key":"1630_CR15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.clml.2013.03.003","volume":"13","author":"H Takasaki","year":"2013","unstructured":"Takasaki H, Hashimoto C, Fujita A, et al. Upfront autologous stem cell transplantation for untreated high-risk diffuse large B-cell lymphoma in patients up to 60\u00a0years of age. Clin Lymphoma Myeloma Leuk. 2013;13:404\u20139.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1630_CR16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12185-013-1444-3","volume":"98","author":"U Tateishi","year":"2013","unstructured":"Tateishi U. PET\/CT in malignant lymphoma: basic information, clinical application, and proposal. Int J Hematol. 2013;98:398\u2013405.","journal-title":"Int J Hematol"},{"key":"1630_CR17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/ajh.20913","volume":"82","author":"MH Abidi","year":"2007","unstructured":"Abidi MH, Tove I, Ibrahim RB, et al. Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant. Am J Hematol. 2007;82:932\u20133.","journal-title":"Am J Hematol"},{"key":"1630_CR18","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1002\/cncr.26712","volume":"118","author":"N Shukla","year":"2012","unstructured":"Shukla N, Kobos R, Renaud T, et al. Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab. Cancer. 2012;118:3719\u201324.","journal-title":"Cancer"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1630-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-014-1630-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-014-1630-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:11:20Z","timestamp":1559437880000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-014-1630-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,26]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["1630"],"URL":"https:\/\/doi.org\/10.1007\/s12185-014-1630-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,26]]}}}